Powerful Medical Receives €40 Million IPCEI Grant — read the full story

Get access

Powerful Medical Webinars & Events

Past Webinars & Events

Best Science Pitch and Overall Winner at AHA Health Tech Competition 2024

Past
Award
November 18, 2024
8:00 -
12:00

Powerful Medical has been named the Best Science Pitch and Overall Winner at the prestigious American Heart Association (AHA) Health Tech Competition during the AHA 2024 Scientific Sessions held in Chicago, Illinois. This recognition underscores Powerful Medical’s leadership in innovative cardiovascular healthcare technology, with its flagship product, PMcardio, earning acclaim as a groundbreaking solution for diagnostics and care coordination.

Learn more

AHA2024 Scientific Sessions: External Independent Validations of PMcardio

Past
Talk
November 18, 2024
11:00 -
11:45

Join us at American Heart Association Scientific Sessions AHA2024 for a deep dive into the External Independent Validations of PMcardio, also known as the Queen of Hearts, during the “AI in ACS Session”! Explore how AI is transforming acute cardiac care through real-world studies.

Learn more

AI-Powered Smartphone Application for Detection of Left Ventricular Systolic Dysfunction using 12-Lead ECG

Past
Talk
November 18, 2024
11:00 -
11:15

At hashtag#AHA2024, Anthony Demolder, MD will spotlight how PMcardio is advancing heart failure diagnostics by detecting LVEF on the ECG for patients in primary care settings.

Learn more

Deep-learning Assisted ECG-based Emergent Cathlab Activation: First Prospective Implementation of a Smartphone-based System

Past
Talk
November 18, 2024
11:00 -
11:30

We’re proud to announce that Robert Herman, MD will present at AHA2024, unveiling new insights on AI in acute cardiac care! His presentation, “Deep-learning Assisted ECG-based Emergent Cathlab Activation: First Prospective Implementation of a Smartphone-based System,” highlights the role of PMcardio and AI-driven diagnostics in rapid cath lab activation for the chest pain patient pathway.

Learn more

Female Patients with Occlusive Myocardial Infarction without ST Elevation Experience Longer Delays in Receiving Emergent Reperfusion

Past
Talk
November 16, 2024
11:40 -
12:15

Join us at AHA2024 to hear Dr. Timea Kisova discuss a critical topic impacting cardiac care for women. In her talk, “Female Patients with Occlusive Myocardial Infarction without ST Elevation Experience Longer Delays in Receiving Emergent Reperfusion” Dr. Kisova will address disparities in timely intervention for female OMI patients, emphasizing the importance of prompt reperfusion.

Learn more

AHA Congress 2024 – Chicago

Past
Event
November 16, 2024
8:00 -
12:00

We are set to make a significant impact with multiple sessions highlighting our cutting-edge innovations in AI-driven cardiovascular care. Our team, alongside experts from Mount Sinai and Washington University Hospital in St. Louis, will present research demonstrating how our technology enhances diagnostic accuracy, enables early diagnosis, and expedites treatment – offering a glimpse into the future of cardiovascular medicine.

Learn More

Missed out? Subscribe for new webinar dates.

Your submission was successful

Don't miss these

More articles
Doctor holding Roche cobas® pulse point-of-care device displaying PMcardio AI-powered ECG interpretation for real-time heart attack detection at the patient bedside.
  • AI, News, STEMI/OMI

PMcardio Expands Heart Attack Detection to Patient Bedside through Roche cobas® pulse Point of Care Platform

Powerful Medical has partnered with Roche to integrate AI-powered ECG interpretation from PMcardio into the cobas® pulse point-of-care platform. Combined with Roche’s Elecsys® high-sensitivity cardiac Troponin T assay, this solution enables clinicians to rapidly and accurately rule in or rule out heart attacks directly at the patient’s bedside.
Smartphone showing This Week in Cardiology podcast episode featuring PMcardio Queen of Hearts™ AI outperforming physicians in ECG interpretation
  • AI, Podcasts, STEMI/OMI

AI vs MD ECG-Reading for Cath Lab Activation (This Week in Cardiology, by Dr. John Mandrola)

In this episode of This Week in Cardiology, Dr. John Mandrola reviews a study comparing physicians with PMcardio’s Queen of Hearts™ AI. The results show the AI achieved 89% accuracy in detecting subtle STEMI equivalents—far surpassing doctors’ 66%—highlighting its potential to transform early heart attack triage.
More articles

Ready to get started?

Get access

Powerful Medical is redefining the landscape of medical diagnostics with its AI-driven solutions. The company’s certified PMcardio platform revolutionizes the way cardiovascular diseases are detected, offering rapid and accurate diagnostics that pave the way for timely and effective treatment.

Logo of Next Gen EU
Logo of Next Gen EU

Products

Company

Resources

Legal

Envelope Linkedin-in Instagram Facebook-f

© Powerful Medical 2025

Privacy

&

Cookies

Legal

Powerful Medical, Inc. | PMcardio and the PMcardio logo are registered trademarks of Powerful Medical. Additionally, Queen of Hearts is claimed as a trademark of Powerful Medical.

 

PMcardio is CE-marked as class IIb medical device under EU MDR and only certified for marketing in the European Union and the United Kingdom. PMcardio technology has not yet been cleared by the US Food and Drug Administration (FDA) for marketing in the USA. Not all modules of the PMcardio platform may be available in your region.

Prior to use, reference the Instructions for Use, for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

PMcardio is CE-marked as class IIb medical device under EU MDR and only certified for marketing in the European Union and the United Kingdom. PMcardio technology has not yet been cleared by the US Food and Drug Administration (FDA) for marketing in the USA. Not all modules of the PMcardio platform may be available in your region. Prior to use, reference the Instructions for Use, for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

Get access